Kevin Ali
Chief Executive Officer at Organon & Co.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Organon & Co., 3 years.
Organon & Co.
Director · Chief Executive Officer
Chief executive roles
Organon & Co.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 5, 2025 | Organon & Co. | Open-market purchase | +34,000 | $8.81 | $299,540 |
| Mar 31, 2025 | Organon & Co. | Option exercise | +48,758 | — | — |
| Mar 31, 2025 | Organon & Co. | Shares withheld for tax | −26,964 | $14.51 | $391,248 |
| Mar 31, 2025 | Organon & Co. | Option exercise | +38,974 | — | — |
| Mar 31, 2025 | Organon & Co. | Shares withheld for tax | −21,553 | $14.51 | $312,734 |
| Mar 31, 2025 | Organon & Co. | Option exercise | +21,472 | — | — |
| Mar 31, 2025 | Organon & Co. | Shares withheld for tax | −11,875 | $14.51 | $172,306 |
| Feb 20, 2025 | Organon & Co. | Grant or award | +84,222 | — | — |
| Feb 20, 2025 | Organon & Co. | Shares withheld for tax | −46,575 | $14.92 | $694,899 |
| Feb 20, 2025 | Organon & Co. | Grant or award | +15,423 | — | — |
| Feb 20, 2025 | Organon & Co. | Shares withheld for tax | −8,529 | $15.29 | $130,408 |
| Sep 3, 2024 | Organon & Co. | Grant or award | +21,567 | — | — |
| Sep 3, 2024 | Organon & Co. | Shares withheld for tax | −11,927 | $20.35 | $242,714 |
| May 4, 2024 | Organon & Co. | Option exercise | +22,161 | — | — |
| May 4, 2024 | Organon & Co. | Shares withheld for tax | −12,256 | $19.61 | $240,340 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.